Evidence map›Paper›PMID 34386598›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2021

Dehydroepiandrosterone modulates oxidative DNA damage in pancreatic cancer: A case-control study.

Hamid Reza Fazli, Ashraf Mohamadkhani, Hamed Reza Godarzi, Akram Pourshams, Mojtaba Jafari Nia

Open access · goldAbstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Insulin-like growth factor 1 and dehydroepiandrosterone levels in alcoholic liver cirrhosis.JGH open : an open access journal of gastroenterology and hepatology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hamid Reza FazliDepartment of Genetics, Marvdasht Branch Islamic Azad University Marvdasht Iran.
Ashraf MohamadkhaniLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute Shariati Hospital, Tehran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0003-0744-0634
Hamed Reza GodarziDepartment of Genetics, Marvdasht Branch Islamic Azad University Marvdasht Iran.
Akram PourshamsLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute Shariati Hospital, Tehran University of Medical Sciences Tehran Iran.
Mojtaba Jafari NiaDepartment of Biology, Marvdasht Branch Islamic Azad University Marvdasht Iran.
Islamic Azad University, Marvdasht · IRShariati Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimDehydroepiandrosterone (DHEA) has a protective role against several types of cancer, although its mechanisms of action are still unknown, it may be related to the antioxidant effect of DHEA. We hypothesized that DHEA has a preventive effect on the formation of the 8-hydroxy-2'-deoxyguanosine (8-OHdG) DNA adduct in pancreatic cancer patients.

methodsSerum DHEAs were quantified by the ELISA method in 50 pancreatic cancer patients with histopathological diagnosis of adenocarcinoma and 50 matched controls. The amount of 8-OHdG was assessed in peripheral blood leukocyte extracted DNA using a 32P-DNA postlabeling technique.

resultsPancreatic cancer patients had lower serum DHEA levels than healthy controls, although it did not differ significantly. Instead, the 8-OHdG DNA adduct was significantly higher in the case than in the control (

conclusionsThese results indicate that serum DHEA reduces the risk of pancreatic cancer with an anti-DNA damage effect. Hence, the influence of DHEA to prohibit the accumulation of 8-OHdG may be one of its physiological functions.

Indexed as

8‐hydroxy‐2‐deoxyguanosinedehydroepiandrosteroneDNA damagepancreatic cancer

Identifiers

PMID34386598
PMCPMC8341181
OpenAlexW3175920338

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.